CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Current assets:
Cash	$ 1,612,977	$ 3,160,442
Prepaid expenses	113,101	157,550
Deposits and other assets	6,000	1,000
Total current assets	1,732,078	3,318,992
Operating lease right-of-use asset	107,162	145,787
Property and equipment, net (Note 3)	5,788,203	2,895,558
Total assets	7,627,443	6,360,337
Current liabilities:
Accounts payable and accrued expenses	800,901	1,360,644
Deferred compensation (Note 4)	784,255	594,798
Total current liabilities	1,585,156	1,955,442
Operating lease liability	119,951	128,864
Convertible notes payable - affiliates (Note 6)	1,735,507	5,170,610
Total liabilities	3,440,614	7,254,916
Bion's stockholders' equity (deficit):
Common stock, no par value, 250,000,000 shares authorized, 48,044,790 and 43,758,820 shares issued, respectively; 47,340,480 and 43,054,511 shares outstanding, respectively
Additional paid-in capital	131,208,759	123,620,046
Subscription receivable - affiliates (Note 8)	(504,650)	(504,650)
Accumulated deficit	(126,554,853)	(124,047,548)
Total Bion's stockholders’ equity (deficit)	4,149,256	(932,152)
Noncontrolling interest	37,573	37,573
Total equity (deficit)	4,186,829	(894,579)
Total liabilities and deficit	7,627,443	6,360,337
Series A Preferred Stock [Member]
Bion's stockholders' equity (deficit):
Preferred stock
Total equity (deficit)
Series C Preferred Stock [Member]
Bion's stockholders' equity (deficit):
Preferred stock
Total equity (deficit)